BioCentury | Sep 13, 2017
Distillery Techniques

Assays and screens

TECHNOLOGY: Cell-free assays; diagnostic assays A massively parallel method for sequencing ctDNA could be used for early diagnosis of cancer. The method involves analyzing ctDNA in plasma samples by using targeted error correction sequencing (TEC-Seq)...
BioCentury | Aug 18, 2017
Translation in Brief

Next-generation growth spurt

A milestone FDA approval could signal next-generation sequencing tests are on the verge of becoming established players in cancer diagnostics. A series of papers published this week highlights further advances in NGS technology, but the...
BioCentury | Aug 18, 2017
Preclinical News

Papers describe liquid biopsy next-generation sequencing

At least five recently published studies have shown the utility of liquid-based biopsies in cancer detection, suggesting that liquid biopsy next-generation sequencing (NGS) could replace traditional detection methods of PCR and tumor biopsies. In addition,...
BioCentury | Nov 4, 2013
Strategy

Teva blinks

With a deeply experienced CEO known for executing large, transformational deals, Teva Pharmaceutical Industries Ltd. had the chance to do something disruptive. But after the abrupt departure of President and CEO Jeremy Levin last Wednesday,...
BioCentury | Apr 15, 2013
Company News

Hycor, Cogent Diagnostics Ltd. deal

HYBD acquired Cogent for $3 million in cash and notes. Cogent, which develops, manufactures and sells autoimmune diagnostics, had revenues of $1.4 million in the 12 months ended March 31. HYBD plans to adapt Cogent's...
BioCentury | Apr 15, 2013
Clinical News

Hycor regulatory update

Japan granted marketing approval to HYBD's Hy-Tec automated allergy testing product line. International Reagents Corp. (Kobe, Japan) will sell the product. Pricing is based on individual laboratory use. Hycor Biomedical Inc. (HYBD), Irvine, Calif. Business:...
BioCentury | Apr 15, 2013
Clinical News

Hycor regulatory update

France granted marketing approval for HYBD's Hy-Tec automated allergy testing product line. HYBD's Hycor Biomedical SAS subsidiary (Paris, France) will sell the line. Pricing is based upon individual laboratory usage. Hycor Biomedical Inc. (HYBD), Irvine,...
BioCentury | Apr 15, 2013
Clinical News

Hycor regulatory update

The FDA cleared four autoimmune test kits for use with HYBD's Hy-tec automated diagnostic system. The number of tests cleared for the system now numbers 13. Hycor Biomedical Inc. (HYBD), Irvine, Calif. Business: Diagnostics/Imaging WIR...
BioCentury | Apr 15, 2013
Clinical News

Hycor regulatory update

HYBD submitted product registration in France to market its Hy-Tec automated allergy diagnostic system. HYBD has established a French subsidiary, Hycor Biomedical SAS (Paris, France), and expects to launch the product in the second quarter....
BioCentury | Dec 16, 2010
Targets & Mechanisms

Basis for targeting BTK

The CGI Pharmaceuticals Inc. unit of Gilead Sciences Inc. and Roche 's Genentech Inc. unit have jointly identified a new inhibitor of the tyrosine kinase BTK and elucidated two BTK-mediated inflammatory pathways involved in arthritis....
Items per page:
1 - 10 of 52